Based on the median Ki-67 proliferation index of nucleated erythroid cells (28%) and median Hb levels (9.3 g/dL), the individual MDS patients were stratified in very low and mildly reduced groups for each of the 2 parameters. The gene discussed is GSTM1; the disease is myelodysplastic syndrome.